You are here: Home » Companies » News
Business Standard

Glenmark gets USFDA nod for pneumonia treatment generic drug Atovaquone

he approved drug is a generic version of GlaxoSmithKline's Mepron Oral Suspension of similar strength

Press Trust of India  |  New Delhi 

Glenmark gets USFDA nod for pneumonia treatment drug

Pharmaceuticals Thursday said it has received final approval from the US health regulator for Atovaquone, used for prevention and treatment of a type of

Pharmaceuticals Inc., USA has been granted final approval by the Food and Drug Administration (USFDA) for Oral Suspension USP in the strength of 750 mg/5 mL," the company said in a filing.

The approved drug is a generic version of GlaxoSmithKline's Oral Suspension of similar strength.

Quoting IQVIA sales data, said, Oral Suspension market achieved annual sales of approximately $119.1 million.

The company's current portfolio consists of 144 products authorised for distribution in the US marketplace and 55 abbreviated new drug applications (ANDAs) pending approval with the

The company's shares were trading at Rs 633.10 apiece, down 1.26 per cent, on the

First Published: Thu, November 22 2018. 10:45 IST
RECOMMENDED FOR YOU